Bird G S, Putney J W
Calcium Regulation Section, Laboratory of Cellular and Molecular Pharmacology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
J Biol Chem. 1996 Mar 22;271(12):6766-70. doi: 10.1074/jbc.271.12.6766.
In mouse lacrimal acinar cells, microinjection of the metabolically stable analog of inositol 1,4,5-trisphosphate, inositol 2,4,5-trisphosphate ((2,4,5)IP3), stimulated both intracellular Ca2+ mobilization and Ca2+ entry. Microinjection of inositol 1,3,4,5-tetrakisphosphate ((1,3,4,5)IP4), the inositol 1,4,5-trisphosphate-3-kinase product, was ineffective at mobilizing intracellular Ca2+ or activating Ca2+ entry. In lacrimal cells previously microinjected with submaximal levels of (2,4,5)IP3, the subsequent microinjection of low to moderate concentrations of (1,3,4,5)IP4 did not result in additional release of intracellular Ca2+, nor did it potentiate the Ca2+ entry phase attributable to (2,4,5)IP3. However, as previously demonstrated (Bird, G. S. J., Rossier, M. F., Hughes, A. R., Shears, S. B., Armstrong, D. L., and Putney, J. W., Jr. (1991) Nature 352, 162-165), additional injections of (2,4,5)IP3 induced further mobilization of intracellular Ca2+ and increased the elevated and sustained Ca2+ entry phase. Introduction of high concentrations of (1,3,4,5)IP4 appeared to inhibit or block the (2,4,5)IP3-induced Ca2+ entry phase. These results were consistent with the observed effect of (1,3,4,5)IP4 in permeabilized lacrimal cells, where (1,3,4,5)IP4 did not release cellular 45Ca2+ but at high concentrations inhibited the ability of submaximal concentrations of (2,4,5)IP3 to release 45Ca2+. Likewise, injection of a high concentration of (1,3,4,5)IP4 prior to injection of (2,4,5)IP3 blocked both release and influx of Ca2+. The inhibitory action of (1,3,4,5)IP4 on Ca2+ signaling observed in intact cells occurred at concentrations that might be obtained in agonist-stimulated cells. However, in permeabilized cells, (1,3,4,5)IP4 inhibited Ca2+ mobilization at concentrations exceeding those likely to occur in agonist-stimulated cells. These results suggest that physiologically relevant levels of (1,3,4,5)IP4 in the cell cytoplasm do not release Ca2+, nor do they potentiate inositol trisphosphate-induced Ca2+ entry across the plasma membrane. Rather, the possibility is raised that (1,3,4,5)IP4 or one of its metabolites could function as a negative feedback on Ca2+ mobilization by inhibiting inositol 1,4,5-trisphosphate-induced Ca2+ release.
在小鼠泪腺腺泡细胞中,显微注射代谢稳定的肌醇1,4,5 -三磷酸类似物——肌醇2,4,5 -三磷酸((2,4,5)IP3),可刺激细胞内Ca2+动员和Ca2+内流。显微注射肌醇1,4,5 -三磷酸-3 -激酶产物肌醇1,3,4,5 -四磷酸((1,3,4,5)IP4),对动员细胞内Ca2+或激活Ca2+内流无效。在先前已显微注射次最大量(2,4,5)IP3的泪腺细胞中,随后显微注射低至中等浓度的(1,3,4,5)IP4,既不会导致细胞内Ca2+的额外释放,也不会增强由(2,4,5)IP3引起的Ca2+内流阶段。然而,如先前所示(伯德,G.S.J.,罗西耶,M.F.,休斯,A.R.,希尔斯,S.B.,阿姆斯特朗,D.L.,以及普特尼,J.W.,Jr.(1991年)《自然》352, 162 - 165),额外注射(2,4,5)IP3会诱导细胞内Ca2+的进一步动员,并增加升高且持续的Ca2+内流阶段。引入高浓度的(1,3,4,5)IP4似乎会抑制或阻断(2,4,5)IP3诱导的Ca2+内流阶段。这些结果与在通透化泪腺细胞中观察到的(1,3,4,5)IP4的作用一致,在通透化泪腺细胞中,(1,3,4,5)IP4不会释放细胞内的45Ca2+,但在高浓度下会抑制次最大浓度的(2,4,5)IP3释放45Ca2+的能力。同样,在注射(2,4,5)IP3之前注射高浓度的(1,3,4,5)IP4会阻断Ca2+的释放和内流。在完整细胞中观察到的(1,3,4,5)IP4对Ca2+信号传导的抑制作用发生在激动剂刺激细胞中可能达到的浓度。然而,在通透化细胞中,(1,3,4,5)IP4在超过激动剂刺激细胞中可能出现的浓度时抑制Ca2+动员。这些结果表明,细胞质中生理相关水平的(1,3,4,5)IP4不会释放Ca2+,也不会增强肌醇三磷酸诱导的Ca2+跨质膜内流。相反,有人提出(1,3,4,5)IP4或其一种代谢产物可能通过抑制肌醇1,4,5 -三磷酸诱导的Ca2+释放,对Ca2+动员起负反馈作用。